CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Total revenues		$ 42,145	$ 35,972
Total costs of revenues		19,469	21,981
Gross profit		22,676	13,991
Operating expenses:
Sales and marketing		4,619	3,434
Research and development		1,285	1,758
General and administrative		11,009	11,467
Depreciation and amortization		1,611	5,236
Stock-based compensation		989	1,374
Lease abandonment expenses		0	75
Goodwill and intangible asset impairment		495	6,174
Acquisition, integration, and transformation costs		3,446	2,384
Total operating expenses		23,454	31,902
Loss from operations		(778)	(17,911)
Other expense:
Interest expense		(6,858)	(6,995)
Gain on fair value of derivative liability		26	4,829
Gain (loss) on fair value of warrant liabilities		(8)	95
Other expense, net, including interest income		(17)	(16)
Total other expense		(6,857)	(2,087)
Loss before income tax benefit		(7,635)	(19,998)
Income tax benefit		0	2,293
Net loss		(7,635)	(17,705)
Less: net income (loss) attributable to noncontrolling interests		448	(260)
Net loss attributable to UpHealth, Inc.		$ (8,083)	$ (17,445)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)		$ (0.51)	$ (1.21)
Diluted (in dollars per share)		$ (0.51)	$ (1.21)
Weighted average shares outstanding:
Basic (in shares)	[1]	15,730	14,454
Diluted (in shares)	[1]	15,730	14,454
Services
Total revenues		$ 30,941	$ 25,686
Total costs of revenues		13,744	15,758
Licenses and subscriptions
Total revenues		1,936	1,781
Total costs of revenues		319	233
Products
Total revenues		9,268	8,505
Total costs of revenues		$ 5,406	$ 5,990

[1] Amounts as of March 31, 2022 and before that date differ from those published in our prior condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1, Organization and Business). Specifically, the number of common shares outstanding during periods before the Reverse Stock Split are divided by the exchange ratio of 10:1, such that each ten shares of common stock were combined and reconstituted into one share of common stock effective December 8, 2022.